Immunocore Holdings (IMCR) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to -$892.4 million.
- Immunocore Holdings' Enterprise Value rose 99.07% to -$892.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$892.4 million, marking a year-over-year increase of 99.07%. This contributed to the annual value of -$820.4 million for FY2024, which is 8534.29% down from last year.
- According to the latest figures from Q3 2025, Immunocore Holdings' Enterprise Value is -$892.4 million, which was up 99.07% from -$882.8 million recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Enterprise Value ranged from a high of -$321.1 million in Q4 2021 and a low of -$901.3 million during Q3 2024
- For the 5-year period, Immunocore Holdings' Enterprise Value averaged around -$617.0 million, with its median value being -$444.5 million (2023).
- Per our database at Business Quant, Immunocore Holdings' Enterprise Value plummeted by 10339.52% in 2024 and then skyrocketed by 99.07% in 2025.
- Over the past 5 years, Immunocore Holdings' Enterprise Value (Quarter) stood at -$321.1 million in 2021, then decreased by 25.32% to -$402.5 million in 2022, then dropped by 9.98% to -$442.6 million in 2023, then plummeted by 85.34% to -$820.4 million in 2024, then decreased by 8.77% to -$892.4 million in 2025.
- Its last three reported values are -$892.4 million in Q3 2025, -$882.8 million for Q2 2025, and -$837.0 million during Q1 2025.